最高の結腸癌医師 - トップ124名の医師

腫瘍生物学・免疫学および全身療法（免疫療法・分子標的療法）に関する査読付き論文を40本以上執筆し、トルコ腫瘍内科学会およびEuropean Head & Neck Societyの会員である。

患者がビュレント・カラゴズ医師を選ぶ理由：

• アナドル病院と米国の主要医療センターであるジョンズ・ホプキンス・メディシンとの戦略的提携のもと、米国の診療プロトコルに基づいた治療を提供。
• 腫瘍生物学・免疫学および全身療法（免疫療法・分子標的療法）に関する査読付き論文40本以上を執筆。
• 元診療部長（GATA）および教授・学科長（Okan大学、トルコ）として、主要医療センターにおける管理・臨床両面での豊富な経験を有する。
• 乳癌、肺癌、大腸癌などの固形腫瘍を対象に、腫瘍生物学に基づいた最新の治療レジメンを実施。
• アナドル病院はESMO認定およびJCI認定を取得しており、国際的なプロトコルに従い、多職種チームによる連携のもと、厳格な安全管理のもとで治療を提供。

腫瘍内科分野においてトルコ国内第3位にランクされており、タンルクル医師はアナドル医療センターの腫瘍内科ユニットを率いています。

• 21年の経験の経験を持つ腫瘍内科の専門医
• がん治療に関する国際臨床試験の主任研究者
• マルマラ大学をはじめとするトルコの名門大学で研鑽を積む
• 個別化化学療法プロトコルを専門とする

1,100件以上の治療実績 – ムスタファ・ソラク准教授は、ヒサル・インターコンチネンタル病院において、結腸癌を含む消化器癌を専門としています。

• 臨床腫瘍学における20年の経験の経験
• ハジェテペ大学癌研究所にてフェローシップ研修修了
• テキサス大学MDアンダーソン癌センター勤務歴あり
• 乳癌、精巣癌、卵巣癌、肺癌、頭頸部癌を専門とする

ワフィイ・アタライ医師は、17年の経験を持つ熟練した腫瘍外科医および一般外科医です。膵臓、結腸・直腸、肝臓に対する手術を専門とし、高度な内視鏡的処置も実施しています。国内外の学術誌に31本の論文を発表し、医学文献に多大な貢献をしています。

第20回学術大会における研究論文コンテストで第1位を受賞したほか、第5回外科学会議においても最優秀研究賞を受賞しています。TSS、パレスチナ医師会、およびIOAの会員として活動しており、これらの組織への積極的な参加は、外科分野における継続的な専門的成長と卓越性への取り組みを示しています。

Kivanc Derya Peker教授は、Hisar Hospital Intercontinentalにて複雑な消化器外科手術を専門とし、400件以上の膵臓癌および胃癌手術を執刀してきました。

• メイヨー・クリニックにて肝胆膵外科のトレーニングを受けた経歴を持つ
• Bakirkoy Dr. Sadi Konuk病院における肝胆膵外科ユニットの創設者
• 肝臓・膵臓・胃癌手術の専門家
• 肥満・代謝外科および内視鏡的治療を専門とする

Assoc. Prof. Gorkem Turkkan started his medical education at Gülhane Military Medical Academy in 2003 and completed it at Zonguldak Karaelmas (Bülent Ecevit) University Faculty of Medicine in 2009. He completed his specialization at Trakya University Faculty of Medicine, Department of Radiation Oncology and became a radiation oncology specialist in 2016.

After completing his compulsory service, he served as a Lecturer and Head of Department at Muğla Sıtkı Koçman University Faculty of Medicine, Department of Radiation Oncology, from May 2019 to February 2021. Meanwhile, between March and June 2020, he worked as a clinical researcher at Maastricht University Faculty of Medicine Department of Radiation Oncology – MAASTRO Clinic (Netherlands) on stereotactic radiotherapy, thoracic radiotherapy-related lung toxicity and proton therapy. While he was working at İstinye University Faculty of Medicine, Department of Radiation Oncology and Liv Hospital Ulus Radiation Oncology Clinic between March 2021 and April 2023, he received the title of Associate Professor in February 2023. She has been serving her patients at Hisar Hospital Intercontinental since May 2023.

He has performed both traditional radiotherapy and advanced radiotherapy throughout his career. He is one of the experienced physicians in our country in stereotactic radiotherapy and MRI-guided radiotherapy treatments, which have become increasingly popular and used especially recently. So far, he has successfully completed more than 2500 radiotherapy sessions with the MR-Linac device.

He has been a member of the Turkish Society of Radiation Oncology (TROD) since 2013 and the European Society of Radiotherapy and Oncology (ESTRO) since 2015. He has 27 articles published in domestic and international journals, 31 oral-poster presentations presented at national and international congresses, and 5 book chapters published by national and international publishing houses. He taught Term I and Term V undergraduate courses at Muğla Sıtkı Koçman University Faculty of Medicine, postgraduate courses within the scope of Ear Nose and Throat Department Specialization training, and Radiotherapy associate degree courses at İstinye University Vocational School of Health Services. She is currently working on 2 ongoing TÜBİTAK Projects. He is married and has a son.

MEDICAL INTERESTS

MR-Linac

Linac

Stereotactic (Pinpoint) Radiotherapy

Prostate Cancers

Breast Cancers

Lung Cancers

Rectum Cancers

Brain and Spinal Cord Cancers

Head and Neck Cancers

Volumetric Arc Therapy (VMAT)

Intensity Modulated Radiotherapy (IMRT)

Assoc. Prof. Dr. Abdulcabbar Kartal is a distinguished colorectal and general surgeon practicing at Anadolu Medical Center in Istanbul. With over 17 years of surgical experience, he specializes in colorectal surgery, HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal cancers, bariatric surgery, and minimally invasive procedures.

Dr. Kartal graduated from Istanbul University Faculty of Medicine in 2007 and completed his general surgery specialization at Istanbul Şişli Etfal Training and Research Hospital (2007-2013). He served as Assistant Professor at Istanbul Okan University (2016-2020) before receiving his Associate Professor title in 2020. In 2021, he earned the prestigious FEBS-C certification from the European Society of Coloproctology and became a Fellow of the American College of Surgeons (FACS).

Dr. Kartal has published over 40 articles in international peer-reviewed journals and is an active member of the Turkish Society of Colon and Rectal Surgery, European Society of Coloproctology, and Turkish Surgical Association.

12,000件以上の腹腔鏡手術を実施 – バジェスタ医師は、ダ・ヴィンチロボット支援による低侵襲大腸癌手術を専門としています。

• 消化器外科における46年の経験年の臨床経験
• Centro Médico Teknon 腹腔鏡センター長
• 複雑な大腸直腸癌症例を専門とする
• 高度腹腔鏡技術において世界中の外科医を指導

パッフェンバッハ教授は、ゾーリンゲン病院において年間9,000件以上の内視鏡的介入を実施しています。

• 腸腫瘍センター長
• 34年の経験 の臨床および外科的実務経験
• 内臓悪性腫瘍を専門とする
• 130件以上の学術論文の著者
• 欧州消化器病・内視鏡学会会員

Dr. Banu Atalar is a board-certified radiation oncologist (Türkiye, 2004). She is a Full Professor at Acibadem MAA University (2018–present) and a clinician at Anadolu Medical Center (2026–present). She trained at Istanbul and Cerrahpaşa. In 2011, she completed a Stanford clinical research fellowship in stereotactic radiosurgery. Her practice focuses on CNS, thoracic, and GI tumors. About 75% of her care involves SRS and MR‑guided adaptive SRS.

Her honors include the ASCO IDEA award (2004), the IASLC International Mentorship Award (2018), and H.FACR (2025). She has 72 international peer‑reviewed publications. Her leadership roles include President of the Turkish Society for Radiation Oncology (2025–27) and Chair of the ESTRO National Societies Committee (2024–27). She served on the ASCO Resource‑Stratified Guidelines Committee (2013–18) and on RSS meeting and nomination committees. She organized national congresses (2023, 2025) and has been an invited speaker at major meetings.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

ガレニア病院にて大腸癌を専門とする外科腫瘍学専門医 – メキシコの一流医療機関にて研鑽を積む。

• 2030年までConacemにより専門医認定取得
• メキシコ腫瘍学会（Sociedad Mexicana de Oncología）会員
• 2020年よりアナワク大学（Universidad Anahuac）にて大学教員を務める
• 国立医療センター11月20日病院（Centro Medico Nacional 20 de Noviembre）にて研修

ペレス・シャロン医師は、欧州屈指のがんセンターであるロイヤル・マースデン病院で研鑽を積み、消化器がんを専門としています。イキロフ病院の消化器腫瘍研究所を率いています。

• 腹腔内温熱化学療法（HIPEC）および大腸がん分子標的治療の専門家
• テルアビブ大学医学部にて講師を務める
• 膵腺癌治療に関する研究論文を発表
• イスラエル腫瘍放射線学会会員

オフェル・メリムスキー教授は、イスラエルを代表するがん専門病院であるスーラスキー医療センターの軟部組織・骨腫瘍科を率いています。

• 肉腫および複雑な腫瘍症例を専門とする41年の経験の経歴
• 欧州を代表するがんセンター、ギュスターブ・ルシー研究所にてフェローシップ研修を修了
• 肉腫治療プロトコルに関するESMOファカルティメンバー
• 革新的ながん治療に関する研究を多数発表

Prof. Nadir Arber is a top gastroenterologist from Israel with over 30 years of experience in the field. He is specialized in the prevention, early diagnostics, and treatment of GI cancers, with education from Hebrew University, Tel Aviv University, and NewYork-Presbyterian Center. He has written over 300 papers on his research and is a member of numerous organizations in the field.

Dr. Jaroslav Tvaruzek is a specialist in robotic surgery. Dr. Tvaruzek is a leading certified expert by Intuitive Surgical - the American produced of the original Da Vinci robots. The doctor is a member of Association of Aesthetic Medicine and Association of Bariatric Surgery.

Dr. Tvaruzek heads the Center of Robotic Surgery located in the St. Zdislava Hospital (the Czech Republic). The doctor has performed over 3,500 robotic surgeries for his practice. Among them are:

• prostatectomy with preservation of the erectile function
• transoral surgeries (removal tumors of the nasopharynx, larynx, trachea, mouth)
• thyroidectomy
• nephrectomy
• bariatric surgeries (surgical treatment of obesity).

Head of Teaching at the Puerto Vallarta Regional Hospital

2020-2023

Medical records manager at the Regional Hospital of Puerto Vallarta 2 months 2020

General practitioner in private medical office

2015-2022

Doctor in charge of weight control clinic

2013-2014

Medical assistant in dermatology clinic

2008-2013

Medical Assistant in Dermatological procedures.

 Medical Assistant in minimally invasive surgical procedures

 Operation of fractional laser machine - IPIXEL-ER and

facial rejuvenation with IPL.

 Experience in laser hair removal with Intense Pulsed Light and

radiofrequency

 Experience with ultrasonic cavitation

 Experience with ultraviolet (UV) light phototherapy machine for the

treatment of psoriasis and vitiligo.

 Experience assisting in Botox and Fillers procedures.

 Biomagnet certified by the Higher Institute of Biomagnetism

doctor ISAAC GOIZ DURAN

 Experience in clinical records

 Training in continuing education and professional development of teachers

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations